Literature DB >> 34386964

Constraining TAT Peptide by γPNA Hairpin for Enhanced Cellular Delivery of Biomolecules.

Siddhartha Thennakoon1, Rick Postema1, Xiaohong Tan2.   

Abstract

Based on the exceptionally high stability of γPNA (Gamma-modified peptide nucleic acid) duplexes, we designed a peptide/γPNA chimera in which a cell-penetrating TAT (HIV Tat-derived) peptide is flanked by two short complementary γPNA segments. Intramolecular hybridization of the γPNA segments results in a stable hairpin conformation in which the TAT peptide is constrained to form the loop. The TAT/γPNA hairpin (self-cyclized TAT peptide) enters cells at least tenfold more efficiently than its nonhairpin analog in which the two γPNA segments are noncomplementary. Extending one of the γPNA segments in the hairpin results in an overhang that can be used for binding and delivering a variety of nucleic acid-conjugated molecules into cells via hybridization to the overhang. We demonstrated efficient cellular delivery of an anti-telomerase γPNA that specifically reduced telomerase activity of A549 cells by over 97%.
© 2021. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cellular delivery; Hairpin; Self-cyclization; TAT peptide; γPNA

Mesh:

Substances:

Year:  2021        PMID: 34386964     DOI: 10.1007/978-1-0716-1617-8_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  16 in total

1.  Transvascular delivery of small interfering RNA to the central nervous system.

Authors:  Priti Kumar; Haoquan Wu; Jodi L McBride; Kyeong-Eun Jung; Moon Hee Kim; Beverly L Davidson; Sang Kyung Lee; Premlata Shankar; N Manjunath
Journal:  Nature       Date:  2007-06-17       Impact factor: 49.962

2.  Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo.

Authors:  M Pooga; U Soomets; M Hällbrink; A Valkna; K Saar; K Rezaei; U Kahl; J X Hao; X J Xu; Z Wiesenfeld-Hallin; T Hökfelt; T Bartfai; U Langel
Journal:  Nat Biotechnol       Date:  1998-09       Impact factor: 54.908

Review 3.  Contemporary strategies for peptide macrocyclization.

Authors:  Christopher J White; Andrei K Yudin
Journal:  Nat Chem       Date:  2011-06-23       Impact factor: 24.427

4.  Exploiting cell surface thiols to enhance cellular uptake.

Authors:  Adrian G Torres; Michael J Gait
Journal:  Trends Biotechnol       Date:  2012-01-17       Impact factor: 19.536

5.  A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus.

Authors:  E Vivès; P Brodin; B Lebleu
Journal:  J Biol Chem       Date:  1997-06-20       Impact factor: 5.157

6.  In vivo protein transduction: delivery of a biologically active protein into the mouse.

Authors:  S R Schwarze; A Ho; A Vocero-Akbani; S F Dowdy
Journal:  Science       Date:  1999-09-03       Impact factor: 47.728

7.  Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes.

Authors:  Vladimir P Torchilin; Tatyana S Levchenko; Ram Rammohan; Natalia Volodina; Brigitte Papahadjopoulos-Sternberg; Gerard G M D'Souza
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-05       Impact factor: 11.205

8.  On-bead cyclization in a combinatorial library of 15,625 octapeptides.

Authors:  Viviana S Fluxa; Jean-Louis Reymond
Journal:  Bioorg Med Chem       Date:  2008-01-30       Impact factor: 3.641

9.  Backbone rigidity and static presentation of guanidinium groups increases cellular uptake of arginine-rich cell-penetrating peptides.

Authors:  Gisela Lättig-Tünnemann; Manuel Prinz; Daniel Hoffmann; Joachim Behlke; Caroline Palm-Apergi; Ingo Morano; Henry D Herce; M Cristina Cardoso
Journal:  Nat Commun       Date:  2011-08-30       Impact factor: 14.919

10.  Tat-mediated delivery of heterologous proteins into cells.

Authors:  S Fawell; J Seery; Y Daikh; C Moore; L L Chen; B Pepinsky; J Barsoum
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.